Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3522 Cr | ₹8161 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 32% | 21% |
Expense Ratio | 1.94 | 1.82 |
Manager | Pradeep Kesavan | Sailesh Raj Bhan |
ISIN Code | INF200K01446 | INF204K01968 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 3.97% | 3.67% |
6 Month | -1.44% | -6.69% |
1 Year | 20.37% | 14.96% |
3 Year | 22.5% | 18.1% |
5 Year | 25.09% | 22.53% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 0.21% | -1.18% |
1 Year | 9.72% | 1.14% |
3 Year | 28.06% | 23.16% |
5 Year | 22.69% | 19.24% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 15.04% | 18.19% |
3 Year | 17.32% | 20.5% |
5 Year | 12.58% | 20.36% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 14.597% | 15.623% |
Sharp | 0.987% | 0.707% |
Beta | 0.85% | 0.908% |
Alpha | 4.505% | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Pradeep Kesavan | Sailesh Raj Bhan |
Total AUM | ₹434274 Cr | ₹96086 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 6.48 | 1.36 |
Small Cap | 37.63 | 27.14 |
Mid Cap | 28.02 | 32.78 |
Large Cap | 27.87 | 38.72 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.8 | 1.36 |
Basic Materials | 6.85 | - |
Healthcare | 91.34 | 98.64 |
Top Comparisons
Bandhan Bond Fund Income Plan Regular-Growth
3Y Returns6.2%
Axis Long Duration Fund - Regular Plan - Growth
3Y Returns0%
SBI Long Term Equity Fund - Regular Plan- Growth
3Y Returns22.35%
Axis ELSS Tax Saver Fund - Regular Plan - Growth
3Y Returns9.83%
Kotak Floating Rate Fund-Regular Plan-Growth Option
3Y Returns7.17%
HDFC Floating Rate Debt Fund - Growth Option
3Y Returns7.58%
UTI Banking and Financial Services Fund - Regular Plan - Growth Option
3Y Returns16.53%
Quant BFSI Fund Regular - Growth
3Y Returns0%